医薬品偽装防止包装の世界市場2016-2026

◆英語タイトル:Anti-counterfeit Pharmaceutical Packaging Market: APEJ Regional Market to Register Healthy CAGR During the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026
◆商品コード:FMI703035
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2016年12月8日
◆ページ数:210
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:包装
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,100,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、医薬品偽装防止包装の世界市場について調査・分析し、医薬品偽装防止包装の世界市場動向、医薬品偽装防止包装の世界市場規模、市場予測、セグメント別医薬品偽装防止包装市場分析、地域別市場規模(北米市場、南米市場、アジア市場、日本市場、ヨーロッパ市場など)、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

Anti-counterfeit pharmaceutical packaging to barricade the growth of the illicit drugs market
Anti-counterfeit pharmaceutical packaging has comparatively high demand, attributed to increasing demand for safe packaging to combat the illicit drug market. The Mass Encoding Technology segment is estimated to account for a market share of 32.2% in the global anti-counterfeit pharmaceutical packaging market by 2016 end and is expected to witness a further rise of 40 basis points to account for 32.4% by 2026.

Owing to an astonishing CAGR of 13.1%, coupled with the current market share of over 40%, the Track and Trace Technologies segment is projected to be the most attractive segment in the global anti-counterfeit pharmaceutical packaging market over the forecast period.

A slew of restrictive measures to combat the rise of counterfeit medicines is cementing the growth of the global anti-counterfeit pharmaceuticals packaging market

Counterfeit medicines are fake medicines. These may be contaminated or contain wrong ingredients. It is estimated that globally, around 10% – 15% of medicines are counterfeit. This poses a threat to the global pharmaceuticals market. Counterfeit pharmaceutical products affect both, i.e. patients as well as pharma companies with their brand reputation. The rampant counterfeiting of drugs has pushed pharma producers to opt for secure solutions. Anti-counterfeiting packaging is one of the measures that pharma majors are relying on. Pharmaceutical companies have been incorporating anti-counterfeit solutions with their product packages; of these, hologram, bar code, and water is common and considered as a conventional option for the same. However, with advancement in technology, pharmaceutical manufacturers are also integrating new and innovative options with conventional solutions such as integrating authentication overt features with covert elements, forensics, and track & trace elements. These measures have translated into fruitful results for pharmaceutical companies and tier II pharma companies also prefer similar approaches. These effective measures considered by pharma companies resulted in the sudden increase in demand for anti-counterfeit pharmaceutical packaging across the globe.

Track & Trace Technologies segment will be a game changer in the anti-counterfeit pharmaceutical packaging market

Anti-counterfeit pharmaceutical packaging market is segmented on the basis of usage feature as convert features, divert features, forensic markers, tamper evidence and track & trace technologies [sterilisation and identification system]. The track & trace technologies segment is predicted to accumulate US$ 2,742.5 Mn by 2026, registering a substantially surging CAGR of 13.1% over the forecast period with a relatively high value share of more than 40% by 2026. The covert feature segment of the global anti-counterfeit pharmaceutical packaging market was valued at US$ 249.1 Mn in 2015 and is projected to reach a market value of US$ 871.8 Mn by 2026, registering a CAGR of 12.3% during the forecast period. The segment is expected to create incremental $ opportunity of US$ 599.7 Mn between 2016 and 2026.

Smart technologies to push the anti-counterfeit pharmaceutical packaging market ahead during the forecast period

Anti-counterfeit pharmaceutical packaging is segmented on the basis of technology as RFID [active tags, passive tags, semi-active tags], security inks and coatings, security printing and graphics, hologram, mass encoding [Barcode Application, Digital Mass Serialization, Digital Mass Encryption] and others [Electromagnetic, Surveillance Technologies]. The RFID technology segment of the global anti-counterfeit pharmaceutical packaging market was valued at US$ 331.8 Mn in 2015 and is projected to reach a market value of US$ 1,146.8 Mn by 2026, registering a CAGR of 12.3% during the forecast period. The segment is expected to create incremental $ opportunity of US$ 786.8 Mn between 2016 and 2026.

Big players in the segment are all set for an African safari

On the basis of region, North America region is projected to remain dominant in the global anti-counterfeit pharmaceutical packaging market throughout the forecast period. North America was the largest market for anti-counterfeit pharmaceutical packaging, accounting for over 34.0% share of the global market in terms of revenue in 2015. Growth is primarily attributed to North America being the largest pharmaceuticals and biologics research hub, which exports bio-pharma products across all geographies. Furthermore, companies are making significant investments in R&D which is likely to boost growth of the pharmaceutical sector in the region.

Latin America is projected to be the fastest-growing market over the forecast period, with a CAGR of 12.7%. In MEA region the changing economic profile of Africa is influencing local as well as international players to expand in the region. The anti-counterfeit pharmaceutical market in the Middle East & Africa is estimated to expand at a fast-paced CAGR of 11.5% by 2026 owing to the growth in the economy of the region.

3M Track & Trace Solutions and Avery Dennison to lock horns to earn the major share of the market

Some of the major players in the industry such as 3M Track & Trace Solutions are predicted to squash out other contenders and will dominate almost 4.5% share of the entire market. Though Avery Dennison and Sicpa Holdings will give tough competition to the projected market leader during the projection period. This massive and fragmented market is packed with competitors who are offering anti-counterfeit pharmaceutical packaging. In the present scenario targeted companies are likely to cover 12% of the market share and the rest will contribute to 82% of the global anti-counterfeit pharmaceutical packaging market.

【レポートの目次】

Table Of Content

1. Executive Summary

2. Research Methodology

3. Assumptions and Acronyms Used

4. Global Anti-counterfeit Pharmaceuticals Packaging Market Overview

4.1 Introduction

4.1.1 Market Taxonomy

4.1.2 Market Definition

4.2 Enter-Route of Pharmaceutical Counterfeits in Supply Chain

4.2.1 For Online Sales

4.2.2 For Offline Sales

4.3 Pharmaceutical Counterfeiting Mechanism

4.4 Overview – Global Cost of Pharmaceutical Counterfeiting

4.5 Global Anti-counterfeit Pharmaceuticals Packaging Market dynamics

4.5.1 Drivers

4.5.1.1 Supply Side

4.5.1.2 Demand Side

4.5.2 Restraints

4.5.3 Opportunities

4.6 Global Anti-counterfeit Pharmaceuticals Packaging Market Trends

4.7 Segmentation Targeting and Positioning (STP) Analysis

4.8 Global Anti-counterfeit Pharmaceuticals Packaging Market Forecast, 2016–2024

4.9 Global Anti-counterfeit Pharmaceuticals Packaging Regional Pricing Analysis

4.10 Global Anti-counterfeit Pharmaceuticals Packaging Market Snapshot

4.10.1 Market Share By Usage Features

4.10.2 Market Share By Technology

4.10.3 Market Share By Region

4.11 Overview – Most Counterfeited Pharmaceutical Products

4.12 Counterfeiting-Conducive Factor Analysis

4.13 Counterfeiting Impact Analysis

4.13.1 On Brand Owners

4.13.2 On Consumers

5 Global Anti-counterfeit Pharmaceuticals Packaging Market Analysis and Forecast By Usage Features

5.1 Introduction

5.1.1 Market Share and BPS Analysis, By Usage Features

5.1.2 Y-o-Y growth comparison, By Usage Features

5.2 Global Anti-counterfeit Pharmaceutical Packaging Market Size and Forecast By Usage Features

5.2.1 Covert Features

5.2.1.1 Absolute $ Opportunity

5.2.1.2 Market Value Forecast

5.2.2 Overt Features

5.2.2.1 Absolute $ Opportunity

5.2.2.2 Market Value Forecast

5.2.3 Forensic Markers

5.2.3.1 Absolute $ Opportunity

5.2.3.2 Market Value Forecast

5.2.4 Tamper Evidence

5.2.4.1 Absolute $ Opportunity

5.2.4.2 Market Value Forecast

5.2.5 Track & Trace Technologies

5.2.5.1 Serialization Track & Trace

5.2.5.1.1 Absolute $ Opportunity

5.2.5.1.2 Market Value Forecast

5.2.5.2 Identification Systems

5.2.5.3 Absolute $ Opportunity

5.3 Market Value Forecast, Market Attractiveness Analysis, By Usage Features

5.4 Prominent Trends

6 Global Anti-counterfeit Pharmaceuticals Packaging Market Analysis By Technology

6.1 Introduction

6.1.1 Market Share and BPS Analysis, By Technology

6.1.2 Y-o-Y growth comparison, By Technology

6.2 Global Anti-counterfeit Pharmaceuticals Packaging Market Size and Forecast By Technology

6.2.1 RFID

6.2.1.1 Active Tags

6.2.1.1.1 Absolute $ Opportunity

6.2.1.1.2 Market Value Forecast

6.2.1.2 Semi-active Tags

6.2.1.2.1 Absolute $ Opportunity

6.2.1.2.2 Market Value Forecast

6.2.1.3 Passive Tags

6.2.1.3.1 Absolute $ Opportunity

6.2.1.3.2 Market Value Forecast

6.2.2 Security Inks & Coatings

6.2.2.1.1 Absolute $ Opportunity

6.2.2.1.2 Market Value Forecast

6.2.3 Security Printing & Graphics

6.2.3.1.1 Absolute $ Opportunity

6.2.3.1.2 Market Value Forecast

6.2.4 Hologram

6.2.4.1.1 Absolute $ Opportunity

6.2.4.1.2 Market Value Forecast

6.2.5 Mass Encoding

6.2.5.1 Barcode

6.2.5.1.1 Absolute $ Opportunity

6.2.5.1.2 Market Value Forecast

6.2.5.2 Digital Mass Serialization (DMS)

6.2.5.2.1 Absolute $ Opportunity

6.2.5.2.2 Market Value Forecast

6.2.5.3 Digital Mass Encryption (DME)

6.2.5.3.1 Absolute $ Opportunity

6.2.5.3.2 Market Value Forecast

6.2.6 Others

6.2.6.1 Absolute $ Opportunity

6.2.6.2 Market Value Forecast

6.3 Market Attractiveness Analysis, By Technology

6.4 Prominent Trends

7 Global Anti-counterfeit Pharmaceuticals Packaging Market Analysis, By Region

7.1 Introduction

7.1.1 Y-o-Y Growth Projections, By Region

7.1.2 Basis Point Share (BPS) Analysis, By Region

7.2 Market Forecast By Region

7.2.1 North America Market Value Forecast

7.2.2 Latin America Market Value Forecast

7.2.3 Europe Market Value Forecast

7.2.4 Asia-Pacific (APAC) Market Value Forecast

7.2.5 Middle East & Africa Market Value Forecast

7.3 Regional Attractiveness Analysis

8 North America Anti-counterfeit Pharmaceuticals Packaging Market Analysis

8.1 Introduction

8.1.1 Y-o-Y Growth Projections, By Country

8.1.2 Basis Point Share (BPS) Analysis, By Country

8.1.3 Key Trends

8.2 North America Market Forecast

8.2.1 Market Value Forecast By Country

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.2 Market Value Forecast By Usage Features

8.2.2.1 Covert Features

8.2.2.2 Overt Feature

8.2.2.3 Forensic Markers

8.2.2.4 Tamper Evidence

8.2.2.5 Track & Trace Technologies

8.2.2.6 Serialization

8.2.2.7 Identification System

8.2.3 Market Value Forecast By Technology

8.2.3.1 RFID

8.2.3.1.1 Active Tags

8.2.3.1.2 Passive Tags

8.2.3.1.3 Semi-active Tags

8.2.3.2 Security Inks and Coatings

8.2.3.3 Security Printing & Graphics

8.2.3.4 Hologram

8.2.3.5 Mass Encoding

8.2.3.5.1 Barcode Application

8.2.3.5.2 Digital Mass Serialization

8.2.3.5.3 Digital Mass Encryption

8.2.3.6 Others

8.2.4 Market Attractiveness Analysis

8.2.4.1 By Country

8.2.4.2 By Usage Features

8.2.4.3 By Technology

8.2.5 Drivers & Restraints: Impact Analysis

9 Latin America Anti-counterfeit Pharmaceuticals Packaging Market Analysis

9.1 Introduction

9.1.1 Y-o-Y Growth Projections, By Country

9.1.2 Basis Point Share (BPS) Analysis, By Country

9.1.3 Key Trends

9.2 Latin America Market Forecast

9.2.1 Market Value Forecast By Country

9.2.1.1 Mexico

9.2.1.2 Brazil

9.2.1.3 Rest of Latin America

9.2.2 Market Value Forecast By Usage Features

9.2.2.1 Covert Features

9.2.2.2 Overt Feature

9.2.2.3 Forensic Markers

9.2.2.4 Tamper Evidence

9.2.2.5 Track & Trace Technologies

9.2.2.6 Serialization

9.2.2.7 Identification System

9.2.3 Market Value Forecast By Technology

9.2.3.1 RFID

9.2.3.1.1 Active Tags

9.2.3.1.2 Passive Tags

9.2.3.1.3 Semi-active Tags

9.2.3.2 Security Inks and Coatings

9.2.3.3 Security Printing & Graphics

9.2.3.4 Hologram

9.2.3.5 Mass Encoding

9.2.3.5.1 Barcode Application

9.2.3.5.2 Digital Mass Serialization

9.2.3.5.3 Digital Mass Encryption

9.2.3.6 Others

9.2.4 Market Attractiveness Analysis

9.2.4.1 By Country

9.2.4.2 By Usage Features

9.2.4.3 By Technology

9.2.5 Drivers & Restraints: Impact Analysis

10 Eastern Europe Anti-counterfeit Pharmaceuticals Packaging Market Analysis

10.1 Introduction

10.1.1 Y-o-Y Growth Projections, By Country

10.1.2 Basis Point Share (BPS) Analysis, By Country

10.1.3 Key Trends

10.2 Eastern Europe Market Forecast

10.2.1 Market Value Forecast By Country

10.2.1.1 Poland

10.2.1.2 Russia

10.2.1.3 Rest of Eastern Europe

10.2.2 Market Value Forecast By Usage Features

10.2.2.1 Covert Features

10.2.2.2 Overt Feature

10.2.2.3 Forensic Markers

10.2.2.4 Tamper Evidence

10.2.2.5 Track & Trace Technologies

10.2.2.6 Serialization

10.2.2.7 Identification System

10.2.3 Market Value Forecast By Technology

10.2.3.1 RFID

10.2.3.1.1 Active Tags

10.2.3.1.2 Passive Tags

10.2.3.1.3 Semi-active Tags

10.2.3.2 Security Inks and Coatings

10.2.3.3 Security Printing & Graphics

10.2.3.4 Hologram

10.2.3.5 Mass Encoding

10.2.3.5.1 Barcode Application

10.2.3.5.2 Digital Mass Serialization

10.2.3.5.3 Digital Mass Encryption

10.2.3.6 Others

10.2.4 Market Attractiveness Analysis

10.2.4.1 By Country

10.2.4.2 By Usage Features

10.2.4.3 By Technology

10.2.5 Drivers & Restraints: Impact Analysis

11 Western Europe Anti-counterfeit Pharmaceuticals Packaging Market Analysis

11.1 Introduction

11.1.1 Y-o-Y Growth Projections, By Country

11.1.2 Basis Point Share (BPS) Analysis, By Country

11.1.3 Key Trends

11.2 Western Europe Market Forecast

11.2.1 Market Value Forecast By Country

11.2.1.1 Germany

11.2.1.2 France

11.2.1.3 U.K

11.2.1.4 Italy

11.2.1.5 Spain

11.2.1.6 BENELUX

11.2.1.7 Rest of Western Europe

11.2.2 Market Value Forecast By Usage Features

11.2.2.1 Covert Features

11.2.2.2 Overt Feature

11.2.2.3 Forensic Markers

11.2.2.4 Tamper Evidence

11.2.2.5 Track & Trace Technologies

11.2.2.6 Serialization

11.2.2.7 Identification System

11.2.3 Market Value Forecast By Technology

11.2.3.1 RFID

11.2.3.1.1 Active Tags

11.2.3.1.2 Passive Tags

11.2.3.1.3 Semi-active Tags

11.2.3.2 Security Inks and Coatings

11.2.3.3 Security Printing & Graphics

11.2.3.4 Hologram

11.2.3.5 Mass Encoding

11.2.3.5.1 Barcode Application

11.2.3.5.2 Digital Mass Serialization

11.2.3.5.3 Digital Mass Encryption

11.2.3.6 Others



【レポートのキーワード】

医薬品偽装防止包装

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医薬品偽装防止包装の世界市場2016-2026(Anti-counterfeit Pharmaceutical Packaging Market: APEJ Regional Market to Register Healthy CAGR During the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆